New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
09:09 EDTMNKDMannKind price target raised to $15 from $12 at Brinson Patrick
Brinson Patrick raised its price target for MannKind shares to $15 citing the FDA Approval of Afrezza for diabetes. The firm says the labeling, REMS program, and post-marketing requirements exceeded its expectations. It keeps an Outperform rating on the stock.
News For MNKD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
05:52 EDTMNKDStocks with implied volatility movement; MNKD LOCO
Subscribe for More Information
05:39 EDTMNKDMannKind, Sanofi on track to launch Afrezza in Q1, says Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use